GRIO


MEUNIER

Pr Pierre-Jean MEUNIER

xxxx


Présentation > Les membres du Comité Directeur > Pr Pierre-Jean MEUNIER > Publications

PUBLICATIONS RÉCENTES


Marquis P, Roux C, de la Loge C, Diaz-Curiel M, Cormier C, Isaia G, Badurski J, Wark J, Meunier PJ. Strontium ranelate prevents quality of life impairment in post-menopausal women with established vertebral osteoporosis. Osteoporos Int. 2008;19(4):503-10. Epub 2007 Oct 11

Arlot ME, Jiang Y, Genant HK, Zhao J, Burt-Pichat B, Roux JP, Delmas PD, Meunier PJ. Histomorphometric and microCT analysis of bone biopsies from postmenopausal osteoporotic women treated with strontium ranelate. J Bone Miner Res. 2008;23(2):215-22

Portero-Muzy NR, Chavassieux PM, Mitton D, Duboeuf F, Delmas PD, Meunier PJ. Euler(strut.cavity), a new histomorphometric parameter of connectivity reflects bone strength and speed of sound in trabecular bone from human os calcis. Calcif Tissue Int. 2007;81(2):92-8. Epub 2007 Jul 18

Durosier C, Hans D, Krieg MA, Ruffieux C, Cornuz J, Meunier PJ, Schott AM. Combining clinical factors and quantitative ultrasound improves the detection of women both at low and high risk for hip fracture. Osteoporos Int. 2007;18(12):1651-9. Epub 2007 Jul 11

Devogelaer JP, Brown JP, Burckhardt P, Meunier PJ, Goemaere S, Lippuner K, Body JJ, Samsioe G, Felsenberg D, Fashola T, Sanna L, Ortmann CE, Trechsel U, Krasnow J, Eriksen EF, Garnero P. Zoledronic acid efficacy and safety over five years in postmenopausal osteoporosis. Osteoporos Int. 2007;18(9):1211-8. Epub 2007 May 22

Siris ES, Lyles KW, Singer FR, Meunier PJ. Medical management of Paget's disease of bone: indications for treatment and review of current therapies. J Bone Miner Res. 2006;21 Suppl 2:P94-8. Review

Follet H, Peyrin F, Vidal-Salle E, Bonnassie A, Rumelhart C, Meunier PJ. Intrinsic mechanical properties of trabecular calcaneus determined by finite-element models using 3D synchrotron microtomography. J Biomech. 2007;40(10):2174-83. Epub 2006 Dec 29

Schott AM, Ganne C, Hans D, Monnier G, Gauchoux R, Krieg MA, Delmas PD, Meunier PJ, Colin C. Which screening strategy using BMD measurements would be most cost effective for hip fracture prevention in elderly women? A decision analysis based on a Markov model. Osteoporos Int. 2007 Feb18(2):143-51. Epub 2006 Oct 13

Bouee S, Lafuma A, Fagnani F, Meunier PJ, Reginster JY. Estimation of direct unit costs associated with non-vertebral osteoporotic fractures in five European countries. Rheumatol Int. 2006;26(12):1063-72. Epub 2006 Sep 5. Review

Harinarayan CV, Kochupillai N, Madhu SV, Gupta N, Meunier PJ. Fluorotoxic metabolic bone disease: an osteo-renal syndrome caused by excess fluoride ingestion in the tropics. Bone. 2006;39(4):907-14. Epub 2006 Jun 15

Boonen S, Bischoff-Ferrari HA, Cooper C, Lips P, Ljunggren O, Meunier PJ, Reginster JY. Addressing the musculoskeletal components of fracture risk with calcium and vitamin D: a review of the evidence. Calcif Tissue Int. 2006;78(5):257-70. Epub 2006 Apr 21. Review

Roux C, Reginster JY, Fechtenbaum J, Kolta S, Sawicki A, Tulassay Z, Luisetto G, Padrino JM, Doyle D, Prince R, Fardellone P, Sorensen OH, Meunier PJ. Vertebral fracture risk reduction with strontium ranelate in women with postmenopausal osteoporosis is independent of baseline risk factors. J Bone Miner Res. 2006;21(4):536-42. Epub 2006 Apr 5

Guinot C, Ezzedine K, Mauger E, Ambroisine L, Latreille J, Bertrais S, Preziosi P, Galan P, Chapuy MC, Arnaud S, Meunier PJ, Tschachler E, Hercberg S, Malvy D. [Phototype, vitamin D status and bone mineral density among women at risk of osteoporosis] Rev Med Interne. 2006;27(5):369-74. Epub 2006 Mar 3. French

Chevrel G, Schott AM, Fontanges E, Charrin JE, Lina-Granade G, Duboeuf F, Garnero P, Arlot M, Raynal C, Meunier PJ. Effects of oral alendronate on BMD in adult patients with osteogenesis imperfecta: a 3-year randomized placebo-controlled trial. J Bone Miner Res. 2006;21(2):300-6. Epub 2005 Oct 24

de la Loge C, Sullivan K, Pinkney R, Marquis P, Roux C, Meunier PJ. Cross-cultural validation and analysis of responsiveness of the QUALIOST: QUAlity of Life questionnaire In OSTeoporosis. Health Qual Life Outcomes. 2005 Nov 10;3:69

Schott AM, Hans D, Duboeuf F, Dargent-Molina P, Hajri T, Bréart G, Meunier PJ; EPIDOS Study Group. Quantitative ultrasound parameters as well as bone mineral density are better predictors of trochanteric than cervical hip fractures in elderly women. Results from the EPIDOS study. Bone. 2005;37(6):858-63. Epub 2005 Oct 14

Portero NR, Arlot ME, Roux JP, Duboeuf F, Chavassieux PM, Meunier PJ. Evaluation and development of automatic two-dimensional measurements of histomorphometric parameters reflecting trabecular bone connectivity: correlations with dual-energy x-ray absorptiometry and quantitative ultrasound in human calcaneum. Calcif Tissue Int. 2005;77(4):195-204. Epub 2005 Sep 28

Farlay D, Boivin G, Panczer G, Lalande A, Meunier PJ. Long-term strontium ranelate administration in monkeys preserves characteristics of bone mineral crystals and degree of mineralization of bone. J Bone Miner Res. 2005;20(9):1569-78. Epub 2005 Apr 27

Szulc P, Duboeuf F, Schott AM, Dargent-Molina P, Meunier PJ, Delmas PD. Structural determinants of hip fracture in elderly women: re-analysis of the data from the EPIDOS study. Osteoporos Int. 2006;17(2):231-6. Epub 2005 Jun 28

Arlot M, Meunier PJ, Boivin G, Haddock L, Tamayo J, Correa-Rotter R, Jasqui S, Donley DW, Dalsky GP, Martin JS, Eriksen EF. Differential effects of teriparatide and alendronate on bone remodeling in postmenopausal women assessed by histomorphometric parameters. J Bone Miner Res. 2005;20(7):1244-53. Epub 2005 Mar 14

Johnell O, Kanis JA, Oden A, Johansson H, De Laet C, Delmas P, Eisman JA, Fujiwara S, Kroger H, Mellstrom D, Meunier PJ, Melton LJ 3rd, O'Neill T, Pols H, Reeve J, Silman A, Tenenhouse A. Predictive value of BMD for hip and other fractures. J Bone Miner Res. 2005;20(7):1185-94. Epub 2005 Mar 7. Erratum in: J Bone Miner Res. 2007 May;22(5):774

De Laet C, Kanis JA, Odén A, Johanson H, Johnell O, Delmas P, Eisman JA, Kroger H, Fujiwara S, Garnero P, McCloskey EV, Mellstrom D, Melton LJ 3rd, Meunier PJ, Pols HA, Reeve J, Silman A, Tenenhouse A. Body mass index as a predictor of fracture risk: a meta-analysis. Osteoporos Int. 2005;16(11):1330-8. Epub 2005 Jun 1. Review

Maurin AC, Chavassieux PM, Meunier PJ. Expression of PPARgamma and beta/delta in human primary osteoblastic cells: influence of polyunsaturated fatty acids. Calcif Tissue Int. 2005;76(5):385-92. Epub 2005 May 5

Follet H, Bruyère-Garnier K, Peyrin F, Roux JP, Arlot ME, Burt-Pichat B, Rumelhart C, Meunier PJ. Relationship between compressive properties of human os calcis cancellous bone and microarchitecture assessed from 2D and 3D synchrotron microtomography. Bone. 2005;36(2):340-51

Boivin G, Vedi S, Purdie DW, Compston JE, Meunier PJ. Influence of estrogen therapy at conventional and high doses on the degree of mineralization of iliac bone tissue: a quantitative microradiographic analysis in postmenopausal women. Bone. 2005;36(3):562-7

Dawson-Hughes B, Heaney RP, Holick MF, Lips P, Meunier PJ, Vieth R. Estimates of optimal vitamin D status. Osteoporos Int. 2005 ul;16(7):713-6. Epub 2005 Mar 18

Meunier PJ, Jenvrin C, Munoz F, de la Gueronnière V, Garnero P, Menz M. Consumption of a high calcium mineral water lowers biochemical indices of bone remodeling in postmenopausal women with low calcium intake. Osteoporos Int. 2005;16(10):1203-9. Epub 2005 Mar 3

Reginster JY, Seeman E, De Vernejoul MC, Adami S, Compston J, Phenekos C, Devogelaer JP, Curiel MD, Sawicki A, Goemaere S, Sorensen OH, Felsenberg D, Meunier PJ. Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study. J Clin Endocrinol Metab. 2005;90(5):2816-22. Epub 2005 Feb 22

Amamra N, Berr C, Clavel-Chapelon F, Delcourt C, Delmas PD, Derriennic F, Ducimetière P, Goldberg M, Letenneur L, Rabilloud M, Meunier PJ, Schott AM. Estimated number of women likely to benefit from bone mineral density measurement in France. Joint Bone Spine. 2004;71(5):409-18. Review

Hans D, Schott AM, Duboeuf F, Durosier C, Meunier PJ; EPIDOS Group. Does follow-up duration influence the ultrasound and DXA prediction of hip fracture? The EPIDOS prospective study. Bone. 2004;35(2):357-63

Chapurlat RD, Hugueny P, Delmas PD, Meunier PJ. Treatment of fibrous dysplasia of bone with intravenous pamidronate: long-term effectiveness and evaluation of predictors of response to treatment. Bone. 2004;35(1):235-42

Robbins JA, Schott AM, Garnero P, Delmas PD, Hans D, Meunier PJ. Risk factors for hip fracture in women with high BMD: EPIDOS study. Osteoporos Int. 2005;16(2):149-54. Epub 2004 Jun 8

Follet H, Boivin G, Rumelhart C, Meunier PJ. The degree of mineralization is a determinant of bone strength: a study on human calcanei. Bone. 2004;34(5):783-9

Boonen S, Rizzoli R, Meunier PJ, Stone M, Nuki G, Syversen U, Lehtonen-Veromaa M, Lips P, Johnell O, Reginster JY. The need for clinical guidance in the use of calcium and vitamin D in the management of osteoporosis: a consensus report. Osteoporos Int. 2004;15(7):511-9


Grados F, Marcelli C, Dargent-Molina P, Roux C, Vergnol JF, Meunier PJ, Fardellone P. Prevalence of vertebral fractures in French women older than 75 years from the EPIDOS study. Bone. 2004 Feb;34(2):362-7.


Meunier PJ, Roux C, Seeman E, Ortolani S, Badurski JE, Spector TD, Cannata J, Balogh A, Lemmel EM, Pors-Nielsen S, Rizzoli R, Genant HK, Reginster JY. The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis. N Engl J Med. 2004;350(5):459-68.


Schott AM, Kassai Koupai B, Hans D, Dargent-Molina P, Ecochard R, Bauer DC, Breart G, Meunier PJ. Should age influence the choice of quantitative bone assessment technique in elderly women? The EPIDOS study. Osteoporos Int. 2004;15(3):196-203


Recker RR, Weinstein RS, Chesnut CH 3rd, Schimmer RC, Mahoney P, Hughes C, Bonvoisin B, Meunier PJ. Histomorphometric evaluation of daily and intermittent oral ibandronate in women with postmenopausal osteoporosis: results from the BONE study. Osteoporos Int. 2004;15(3):231-7

Boivin G, Meunier PJ. Methodological considerations in measurement of bone mineral content. Osteoporos Int. 2003;14 Suppl 5:22-8.


Boivin G, Lips P, Ott SM, Harper KD, Sarkar S, Pinette KV, Meunier PJ. Contribution of raloxifene and calcium and vitamin D3 supplementation to the increase of the degree of mineralization of bone in postmenopausal women. J Clin Endocrinol Metab. 2003;88(9):4199-205.


Boivin G, Meunier PJ. Methodological considerations in measurement of bone mineral content. Osteoporos Int. 2003


Szulc P, Meunier PJ. Synergistic effect of vitamin D and calcium in preventing proximal femoral fractures in older patients. Joint Bone Spine. 2003;70(3):157-60


Boivin G, Meunier PJ. The mineralization of bone tissue: a forgotten dimension in osteoporosis research.
Osteoporos Int. 2003;14 Suppl 3:S19-24.


Boivin G, Meunier PJ. The Degree of Mineralization of Bone Tissue Measured by Computerized Quantitative Contact Microradiography. Calcif Tissue Int. 2002;27

Meunier PJ, Slosman DO, Delmas PD, Sebert JL, Brandi ML, Albanese C, Lorenc R, Pors-Nielsen S, De Vernejoul MC, Roces A, Reginster JY. Strontium ranelate. dose-dependent effects in established postmenopausal vertebral osteoporosis-a 2-year randomized placebo controlled trial. J Clin Endocrinol Metab. 2002;87(5):2060-6

Chapuy MC, Pamphile R, Paris E, Kempf C, Schlichting M, Arnaud S, Garnero P, Meunier PJ. Combined calcium and vitamin D3 supplementation in elderly women. confirmation of reversal of secondary hyperparathyroidism and hip fracture risk. the Decalyos II study. Osteoporos Int. 2002;13(3):257-64

Dalle Carbonare L, Chavassieux PM, Arlot ME, Meunier PJ. Bone histomorphometry in untreated and treated glucocorticoid-induced osteoporosis. Front Horm Res. 2002;30:37-48

Reid IR, Brown JP, Burckhardt P, Horowitz Z, Richardson P, Trechsel U, Widmer A, Devogelaer JP, Kaufman JM, Jaeger P, Body JJ, Brandi ML, Broell J, Di Micco R, Genazzani AR, Felsenberg D, Happ J, Hooper MJ, Ittner J, Leb G, Mallmin H, Murray T, Ortolani S, Rubinacci A, Saaf M, Samsioe G, Verbruggen L, Meunier PJ. Intravenous zoledronic acid in postmenopausal women with low bone mineral density. N Engl J Med. 2002 28;346(9):653-6

Meunier PJ. Anabolic agents for treating postmenopausal osteoporosis. Joint Bone Spine. 2001;68(6):576-81

Chavassieux P, Meunier PJ. Histomorphometric approach of bone loss in men. Calcif Tissue Int. 2001;69(4):209-13

Giraud F, Fontana A, Mallet J, Fischer LP, Meunier PJ. Sciatica caused by epidural gas. Four case reports. Joint Bone Spine. 2001;68(5):434-7

Lyles KW, Siris ES, Singer FR, Meunier PJ. A clinical approach to diagnosis and management of Paget's disease of bone. J Bone Miner Res. 2001;16(8):1379-87

Szulc P, Meunier PJ. Is vitamin K deficiency a risk factor for osteoporosis in Crohn's disease? Lancet. 2001 23;357(9273):1995-6

Vignot E, Meunier PJ. [Use of biochemical markers of bone turnover in Paget's disease of bone] Ann Biol Clin (Paris). 2001;59(3):309-11

Schott AM, Dargent-Molina P, Meunier PJ. The effect of risedronate on the risk of hip fracture in elderly women. N Engl J Med. 2001 31;344(22):1721

Chevrel G, Meunier PJ. Osteogenesis imperfecta. lifelong management is imperative and feasible. Joint Bone Spine. 2001 ;68(2):125-9

McClung MR, Geusens P, Miller PD, Zippel H, Bensen WG, Roux C, Adami S, Fogelman I, Diamond T, Eastell R, Meunier PJ, Reginster JY. Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group. N Engl J Med. 2001 i;344(5):333-40

Dalle Carbonare L, Arlot ME, Chavassieux PM, Roux JP, Portero NR, Meunier PJ. Comparison of trabecular bone microarchitecture and remodeling in glucocorticoid-induced and postmenopausal osteoporosis. J Bone Miner Res. 2001;16(1):97-103

Chavassieux P, Garnero P, Duboeuf F, Vergnaud P, Brunner-Ferber F, Delmas PD, Meunier PJ. Effects of a new selective estrogen receptor modulator (MDL 103,323) on cancellous and cortical bone in ovariectomized ewes. a biochemical, histomorphometric, and densitometric study. J Bone Miner Res. 2001;16(1):89-96

Boivin GY, Chavassieux PM, Santora AC, Yates J, Meunier PJ. Alendronate increases bone strength by increasing the mean degree of mineralization of bone tissue in osteoporotic women. Bone. 2000;27(5):687-94

Tonino RP, Meunier PJ, Emkey R, Rodriguez-Portales JA, Menkes CJ, Wasnich RD, Bone HG, Santora AC, Wu M, Desai R, Ross PD. Skeletal benefits of alendronate. 7-year treatment of postmenopausal osteoporotic women. Phase III Osteoporosis Treatment Study Group. J Clin Endocrinol Metab. 2000;85(9):3109-15

Chapurlat RD, Garnero P, Breart G, Meunier PJ, Delmas PD. Serum estradiol and sex hormone-binding globulin and the risk of hip fracture in elderly women. the EPIDOS study. J Bone Miner Res. 2000;15(9):1835-41

Lecuyer N, Grados F, Dargent-Molina P, Deramond H, Meunier PJ, Fardellone P. Prevalence of Paget's disease of bone and spinal hemangioma in French women older than 75 years. data from the EPIDOS study. Joint Bone Spine. 2000;67(4):315-8

Dernière mise à jour : 17-01-2017